# FDA 483 - Mid-Continent Packaging, Inc - March 07, 2022

Source: https://www.keypedia.com/records/483/mid-continent-packaging-inc/d374b435-7586-4cb3-8e8d-ad12f1695d63

> FDA 483 for Mid-Continent Packaging, Inc on March 07, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Mid-Continent Packaging, Inc
- Inspection Date: 2022-03-07
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: An FDA inspection of Mid-Continent Packaging, Inc. in Enid, OK, an OTC drug manufacturer, revealed a significant quality control issue. The firm failed to determine actual and theoretical yield percentages at the conclusion of each manufacturing phase, instead performing these calculations months after product distribution. This practice led to delayed identification of significant yield discrepancies, indicating a breakdown in process control and record-keeping.

## Related Officers

- [Investigator](https://www.keypedia.com/people/preston-b-hoover/0f805e3f-63f2-4d2d-aeb2-4f6287cfec86)

Company: https://www.keypedia.com/companies/mid-continent-packaging-inc/defbcf33-f02e-469b-9591-6de3b9050825

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab